Screening for structural variants of four candidate genes in dogs

geno-type

CircRNA_100782 promotes roliferation and metastasis of gastric most cancers by downregulating tumor suppressor gene Rb by adsorbing miR-574-3p in a sponge kind

Objective: The purpose of this analysis is to research the expression ranges of circRNA_100782 in gastric most cancers tissues, and its carry out of regulating tumor suppressor gene Rb by absorbing miR-574-3p in a sponge kind.

 

Victims and methods: qRT-PCR was carried out to detect the expressions of circRNA_100782 at completely totally different phases all through gastric most cancers tissues. CCK-Eight assay was carried out to guage the osteoclast proliferation and differentiation. The correlation between miR-574-3p and circRNA_100782 was detected by statistical analysis. Bioinformatics and Luciferase assay have been carried out to find the interaction and binding web site of circRNA_100782 and miR-574-3p. The mice Rb 3′-UTR have been cloned into the Luciferase reporter vector and miR-574-3p binding mutants have been constructed to validate the inhibited regulation of miR-574-3p to the expression of Rb.

 

Outcomes: Throughout the current analysis, in distinction with adjoining non-cancerous common tissues, the expressions of circRNA_100782 and Rb have been every downregulated in human gastric most cancers cells. By way of qRT-PCR and CCK-Eight assay, we found that the expression of circRNA_100782 is expounded to the proliferation of gastric most cancers cells. Along with, we moreover found that circRNA_100782 regulated the migration functionality of gastric most cancers cells by transwell assay.

 

The bioinformatics prediction and luciferase assay demonstrated that circRNA_100782 can perform a molecular sponge to extra regulate the expression of Rb by sponging with miR-574-3p; moreover, circRNA_100782 can perform a ceRNA for miR-574-3p to extra regulate the expression of Rb.

 

Conclusions: On this evaluation, we discovered that circRNA_100782 was downregulated in gastric most cancers cells and is said to cell proliferation and invasion by inhibiting tumor suppressor gene Rb by interacting with miR-574-3p.

geno-type

geno-type

Olaparib

GP0126-100MG 100 mg
EUR 136.8

Olaparib

GP0126-1G 1 g
EUR 514.8

Olaparib

GP0126-250 250
EUR 150.4

Olaparib

GP0126-250MG 250 mg
EUR 217.2

Olaparib

T3015-10mg 10mg Ask for price
Description: Olaparib

Olaparib

T3015-1g 1g Ask for price
Description: Olaparib

Olaparib

T3015-1mg 1mg Ask for price
Description: Olaparib

Olaparib

T3015-50mg 50mg Ask for price
Description: Olaparib

Olaparib

T3015-5mg 5mg Ask for price
Description: Olaparib

Olaparib

HY-10162 2g
EUR 804

Olaparib-d5

T12292-10mg 10mg Ask for price
Description: Olaparib-d5

Olaparib-d5

T12292-1g 1g Ask for price
Description: Olaparib-d5

Olaparib-d5

T12292-1mg 1mg Ask for price
Description: Olaparib-d5

Olaparib-d5

T12292-50mg 50mg Ask for price
Description: Olaparib-d5

Olaparib-d5

T12292-5mg 5mg Ask for price
Description: Olaparib-d5

AZD2281 (Olaparib)

27003 250 mg
EUR 200
Description: AZD2281, also known as Olaparib, is a poly(ADP-ribose) polymerase 1 (PARP1) inhibitor and an anti-cancer drug being tested in patients with mutations in the genes BRCA1 or BRCA2.

Olaparib (AZD2281)

E1KS1060 10mg
EUR 303

Olaparib (AZD-2281)

200422 200.0mg
EUR 90

Olaparib [CAS# 763113-22-0]

O-9201 250 mg
EUR 75

Olaparib (AZD2281, Ku-0059436)

A4154-10 10 mg
EUR 40
Description: Potent PARP1/PARP2 inhibitor

Olaparib (AZD2281, Ku-0059436)

A4154-100 100 mg
EUR 128
Description: Potent PARP1/PARP2 inhibitor

Olaparib (AZD2281, Ku-0059436)

A4154-5.1 10 mM (in 1mL DMSO)
EUR 44
Description: Potent PARP1/PARP2 inhibitor

Olaparib (AZD2281, Ku-0059436)

A4154-500 500 mg
EUR 384
Description: Potent PARP1/PARP2 inhibitor

Olaparib (AZD2281, Ku-0059436)

A4154-S Evaluation Sample
EUR 22
Description: Potent PARP1/PARP2 inhibitor

N-Descyclopropanecarbaldehyde Olaparib

T36571-10mg 10mg Ask for price
Description: N-Descyclopropanecarbaldehyde Olaparib

N-Descyclopropanecarbaldehyde Olaparib

T36571-1g 1g Ask for price
Description: N-Descyclopropanecarbaldehyde Olaparib

N-Descyclopropanecarbaldehyde Olaparib

T36571-1mg 1mg Ask for price
Description: N-Descyclopropanecarbaldehyde Olaparib

N-Descyclopropanecarbaldehyde Olaparib

T36571-50mg 50mg Ask for price
Description: N-Descyclopropanecarbaldehyde Olaparib

N-Descyclopropanecarbaldehyde Olaparib

T36571-5mg 5mg Ask for price
Description: N-Descyclopropanecarbaldehyde Olaparib

Ola1/ Rat Ola1 ELISA Kit

ELI-44591r 96 Tests
EUR 1063.2

Ola1 (untagged ORF) - Rat Obg-like ATPase 1 (Ola1), (10 ug)

RN212538 10 µg Ask for price

Lenti ORF particles, Ola1 (GFP-tagged ORF) - Rat Obg-like ATPase 1 (Ola1), 200ul, >10^7 TU/mL

RR212538L4V 200 µl Ask for price

Ola1 (Myc-DDK-tagged ORF) - Rat Obg-like ATPase 1 (Ola1), (10 ug)

RR212538 10 µg Ask for price

Lenti ORF particles, Ola1 (Myc-DDK-tagged ORF) - Rat Obg-like ATPase 1 (Ola1), 200ul, >10^7 TU/mL

RR212538L3V 200 µl Ask for price

OLA1

enz-637 5µg
EUR 60
Description: Recombinant Human Obg-Like ATPase 1

OLA1

CSB-CL016318HU1 10 μg plasmid + 200μl Glycerol Ask for price

OLA1

CSB-CL016318HU2 10 μg plasmid + 200μl Glycerol Ask for price

Lenti ORF clone of Ola1 (mGFP-tagged ORF) - Rat Obg-like ATPase 1 (Ola1), (10 ug)

RR212538L4 10 µg Ask for price

Lenti ORF clone of Ola1 (Myc-DDK-tagged ORF) - Rat Obg-like ATPase 1 (Ola1), (10 ug)

RR212538L3 10 µg Ask for price

OLA1 siRNA

20-abx926820
  • Ask for price
  • Ask for price
  • 15 nmol
  • 30 nmol

OLA1 siRNA

20-abx926821
  • Ask for price
  • Ask for price
  • 15 nmol
  • 30 nmol

OLA1 siRNA

20-abx903741
  • Ask for price
  • Ask for price
  • 15 nmol
  • 30 nmol

OLA1 (untagged)-Human Obg-like ATPase 1 (OLA1), transcript variant 2

SC323754 10 µg Ask for price

OLA1 (untagged)-Human Obg-like ATPase 1 (OLA1), transcript variant 1

SC115293 10 µg Ask for price

OLA1 (GFP-tagged) - Human Obg-like ATPase 1 (OLA1), transcript variant 2

RG202094 10 µg Ask for price

OLA1 (GFP-tagged) - Human Obg-like ATPase 1 (OLA1), transcript variant 1

RG220834 10 µg Ask for price

Ola1 (untagged) - Mouse Obg-like ATPase 1 (Ola1), transcript variant 1, (10ug)

MC203789 10 µg Ask for price

Ola1 (GFP-tagged) - Mouse Obg-like ATPase 1 (Ola1) transcript variant 2, (10ug)

MG218924 10 µg Ask for price

OLA1 Rabbit pAb

A11671-100ul 100 ul
EUR 369.6

OLA1 Rabbit pAb

A11671-200ul 200 ul
EUR 550.8

OLA1 Rabbit pAb

A11671-20ul 20 ul
EUR 219.6

OLA1 Rabbit pAb

A11671-50ul 50 ul
EUR 267.6

OLA1 Rabbit pAb

A4673-100ul 100 ul
EUR 369.6

OLA1 Rabbit pAb

A4673-200ul 200 ul
EUR 550.8

OLA1 Rabbit pAb

A4673-20ul 20 ul Ask for price

OLA1 Rabbit pAb

A4673-50ul 50 ul Ask for price

OLA1 Rabbit pAb

E2824934 100ul
EUR 225
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

OLA1 Rabbit pAb

E2124934 100ul
EUR 225
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

OLA1 (Myc-DDK-tagged)-Human Obg-like ATPase 1 (OLA1), transcript variant 2

RC202094 10 µg Ask for price

Ola1 (Myc-DDK-tagged) - Mouse Obg-like ATPase 1 (Ola1), transcript variant 1

MR206215 10 µg Ask for price

Ola1 (Myc-DDK-tagged) - Mouse Obg-like ATPase 1 (Ola1), transcript variant 2

MR218924 10 µg Ask for price

OLA1 (Myc-DDK-tagged)-Human Obg-like ATPase 1 (OLA1), transcript variant 1

RC220834 10 µg Ask for price

OLA1 Antibody

47250 100ul
EUR 319

OLA1 Antibody

47250-100ul 100ul
EUR 302.4

OLA1 Antibody

1-CSB-PA016318GA01HU
  • Ask for price
  • Ask for price
  • 150ul
  • 50ul
Description: A polyclonal antibody against OLA1. Recognizes OLA1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF

OLA1 Antibody

1-CSB-PA016318HA01HU
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against OLA1. Recognizes OLA1 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF; Recommended dilution: WB:1:500-1:2000, IHC:1:20-1:200, IF:1:50-1:200

OLA1 Antibody

E047250 100μg/100μl
EUR 255
Description: Available in various conjugation types.

OLA1 Antibody

E94673 100μg
EUR 255
Description: Available in various conjugation types.

OLA1 Antibody

E305127 100ug/200ul
EUR 275
Description: Available in various conjugation types.

OLA1 antibody

70R-19036 50 ul
EUR 289
Description: Rabbit polyclonal OLA1 antibody

OLA1 ELISA KIT|Human

EF010905 96 Tests
EUR 826.8

OLAb/ Rat OLAb ELISA Kit

ELA-E0617r 96 Tests
EUR 1063.2

Olah/ Rat Olah ELISA Kit

ELI-30503r 96 Tests
EUR 1063.2

OLA1 protein (His tag)

80R-2403 100 ug
EUR 444
Description: Purified recombinant Human OLA1 protein (His tag)

Lenti ORF clone of Ola1 (mGFP-tagged) - Mouse Obg-like ATPase 1 (Ola1), transcript variant 1

MR206215L4 10 µg Ask for price

Lenti ORF clone of Ola1 (mGFP-tagged) - Mouse Obg-like ATPase 1 (Ola1), transcript variant 2

MR218924L4 10 µg Ask for price

OLA1 (N-term) Rabbit pAb

E2613169 100ul
EUR 225
Description: Available in various conjugation types.

Ola1 ORF Vector (Rat) (pORF)

ORF071706 1.0 ug DNA
EUR 607.2

Lenti-ORF clone of OLA1 (mGFP-tagged)-Human Obg-like ATPase 1 (OLA1), transcript variant 2

RC202094L4 10 µg Ask for price

Lenti ORF clone of Ola1 (Myc-DDK-tagged) - Mouse Obg-like ATPase 1 (Ola1), transcript variant 1

MR206215L3 10 µg Ask for price

Lenti ORF clone of Ola1 (Myc-DDK-tagged) - Mouse Obg-like ATPase 1 (Ola1), transcript variant 2

MR218924L3 10 µg Ask for price

Rat OLA1 shRNA Plasmid

20-abx988809
  • Ask for price
  • Ask for price
  • 150 µg
  • 300 µg

Lenti-ORF clone of OLA1 (Myc-DDK-tagged)-Human Obg-like ATPase 1 (OLA1), transcript variant 2

RC202094L3 10 µg Ask for price

Lenti ORF particles, Ola1 (GFP-tagged) - Mouse Obg-like ATPase 1 (Ola1), transcript variant 1, 200ul, >10^7 TU/mL

MR206215L4V 200 µl Ask for price

Lenti ORF particles, Ola1 (GFP-tagged) - Mouse Obg-like ATPase 1 (Ola1), transcript variant 2, 200ul, >10^7 TU/mL

MR218924L4V 200 µl Ask for price

OLA1 cloning plasmid

CSB-CL016318HU1-10ug 10ug
EUR 279.6
Description: A cloning plasmid for the OLA1 gene.

OLA1 cloning plasmid

CSB-CL016318HU2-10ug 10ug
EUR 279.6
Description: A cloning plasmid for the OLA1 gene.

OLA1 ORF Vector (Human) (pORF)

ORF007364 1.0 ug DNA
EUR 114

OLA1 ORF Vector (Human) (pORF)

ORF007365 1.0 ug DNA
EUR 114

Ola1 ORF Vector (Mouse) (pORF)

ORF051954 1.0 ug DNA
EUR 607.2

Ola1 ORF Vector (Mouse) (pORF)

ORF051955 1.0 ug DNA
EUR 607.2

OLA1 3'UTR GFP Stable Cell Line

TU066236 1.0 ml
EUR 1825.2

Ola1 3'UTR GFP Stable Cell Line

TU164539 1.0 ml Ask for price

Ola1 3'UTR GFP Stable Cell Line

TU264390 1.0 ml Ask for price

Lenti ORF particles, OLA1 (mGFP-tagged)-Human Obg-like ATPase 1 (OLA1), transcript variant 2, 200ul, >10^7 TU/mL

RC202094L4V 200 µl Ask for price

Lenti ORF particles, OLA1 (Myc-DDK tagged) - Human Obg-like ATPase 1 (OLA1), transcript variant 1, 200ul, >10^7 TU/mL

RC220834L1V 200 µl Ask for price

Lenti ORF particles, OLA1 (mGFP-tagged) - Human Obg-like ATPase 1 (OLA1), transcript variant 1, 200ul, >10^7 TU/mL

RC220834L2V 200 µl Ask for price

Lenti ORF particles, OLA1 (Myc-DDK tagged) - Human Obg-like ATPase 1 (OLA1), transcript variant 1, 200ul, >10^7 TU/mL

RC220834L3V 200 µl Ask for price

Lenti ORF particles, OLA1 (mGFP-tagged) - Human Obg-like ATPase 1 (OLA1), transcript variant 1, 200ul, >10^7 TU/mL

RC220834L4V 200 µl Ask for price

Human OLA1 shRNA Plasmid

20-abx959228
  • Ask for price
  • Ask for price
  • 150 µg
  • 300 µg

 

Preconditioning Impression of Extreme-Depth Interval Teaching (HIIT) and Berberine Supplementation on the Gene Expression of Angiogenesis Regulators and Caspase-Three Protein inside the Rats with Myocardial Ischemia-Reperfusion (IR) Hurt

 

Objective: It has been confirmed that angiogenesis is a captivating remedy for victims with ischemic coronary coronary heart sickness. We received right down to study the have an effect on of high-intensity interval teaching (HIIT) and berberine supplementation on the gene expression of angiogenesis-related elements and caspase-Three protein in rats affected by myocardial ischemic-reperfusion hurt.

 

Methods: Fifty rats have been divided into the following groups: (1) expert, (2) berberine supplemented, (3) blended, and (4) IR. Each cohort underwent 5 durations of HIIT per week for a interval of Eight weeks adopted by induction of ischemia. Seven days after completion of reperfusion, modifications inside the gene expression of angiogenesis-related elements and caspase-Three protein have been evaluated inside the coronary coronary heart tissue.

 

Outcomes: We observed a significant distinction between Four groups inside the transcript ranges of vascular endothelial cell improvement subject (VEGF), fibroblast improvement factor-2 (FGF2), and thrombospondin-1(TSP-1) (p ≤ 0.05). Nonetheless, the excellence in endostatin (ENDO) ranges was not very important among the many many groups no matter a discernible low cost (p ≥ 0.05). Moreover, caspase-Three protein and infarct dimension have been significantly lowered inside the intervention groups (p ≤ 0.05), and cardiac carry out elevated in response to these interventions.

 

Conclusion: The therapies exert their impression, likely, by lowering caspase-Three protein and rising the expression of angiogenesis-promoting elements, concomitant with a reduction in inhibitors of the strategy.

 

Explicit miRNA and Gene Deregulation Characterize the Elevated Angiogenic Remodeling of Thoracic Aneurysmatic Aortopathy in Marfan Syndrome

 

Marfan syndrome (MFS) is a connective tissue sickness introduced on by mutations inside the FBN1 gene, leading to alterations inside the extracellular matrix microfibril assembly and the early formation of thoracic aorta aneurysms (TAAs). Non-genetic TAAs share many clinico-pathological parts with MFS and deregulation of some microRNAs (miRNAs) has been demonstrated to be involved inside the improvement of TAA. On this analysis, 40 victims current course of elective ascending aorta surgical process have been enrolled to match TAA histomorphological choices, miRNA profile and related purpose genes with the intention to find specific alterations that can make clear the earlier and further excessive scientific outcomes in MFS victims.

 

Histomorphological, ultrastructural and in vitro analysis have been carried out with the intention to guage aortic wall choices of MFS and non-MFS TAA. MFS displayed higher glycosaminoglycan accumulation and loss/fragmentation of elastic fibers compared with non-MFS TAA. Immunohistochemistry revealed elevated CD133+ angiogenic remodeling, higher MMP-2 expression, irritation and {{smooth}} muscle cell (SMC) turnover in MFS TAA.

 

Cultured SMCs from MFS confirmed elevated turnover and α-smooth muscle actin expression in distinction with non-MFS TAA. Moreover, twenty-five miRNAs, along with miR-26a, miR-29, miR-143 and miR-145, have been found to be downregulated and solely miR-632 was upregulated in MFS TAA in vivo.

 

Bioinformatics analysis revealed that some deregulated miRNAs in MFS TAA are implicated in cell proliferation, extracellular matrix development/carry out and TGFβ signaling. Lastly, gene analysis confirmed 28 upregulated and seven downregulated genes in MFS TAA, a number of of them belonging to the CDH1/APC and CCNA2/TP53 signaling pathways. Explicit miRNA and gene deregulation characterised the aortopathy of MFS and this was associated to elevated angiogenic remodeling, likely favoring the early and further excessive scientific outcomes, compared with non-MFS TAA.

 

Our findings current new insights regarding the pathogenetic mechanisms of MFS TAA; extra investigation is required to substantiate if these newly acknowledged specific deregulated miRNAs might symbolize potential therapeutic targets to counteract the speedy improvement of MFS aortopathy.

Screening for structural variants of 4 candidate genes in canine with problems of intercourse improvement revealed the primary case of a big deletion in NR5A1

 

Problems of intercourse improvement (DSD) are vital causes of infertility and sterility, and are threat components for gonadal carcinogenesis. Many DSDs are brought on by genetic components, primarily intercourse chromosome abnormalities or mutations of genes concerned in sexual improvement, in addition to structural variants (SVs) – massive deletions, duplications, and insertions, if these overlap genes concerned in intercourse improvement.
The purpose of this examine was to find out if there have been SVs in 4 candidate genes – NR0B1 (DAX1), NR5A1, RSPO1, and SOX3 – utilizing droplet digital PCR (ddPCR). There was examine of two cohorts of canine with DSD, together with 55 animals with XX DSD and 15 with XY DSD.
As well as, 40 management females and 10 management males have been included within the examine. Amongst instances, for which there have been evaluations, a big deletion consisting of 4 exons of the NR5A1 gene was recognized in a Yorkshire Terrier with a rudimentary penis, hypospadias, bilateral cryptorchidism, and spermatogenesis inactive testes. That is the primary mutation within the NR5A1 gene resulting in XY DSD phenotype to be reported in home animals.
There have been no SVs within the genes evaluated within the current examine within the cohort of canine with XX DSD. The outcomes from this examine present proof that the big structural variants of those genes are not often related to the DSD phenotype in canine.

Glycitin

T2820-1g 1g Ask for price
Description: Glycitin

Glycitin

T2820-1mg 1mg Ask for price
Description: Glycitin

Glycitin

T2820-50mg 50mg Ask for price
Description: Glycitin

Glycitin

T2820-5mg 5mg Ask for price
Description: Glycitin

Glycitin

TB0005 25mg
EUR 223.2

Glycitin, >99%

BC036-005 5mg
EUR 230.4

Glycitin, >99%

BC036-010 10mg
EUR 295.2

Glycitin, >99%

BC036-025 25mg
EUR 360

Glycitin 6''-O-Malonate

G635425 100mg
EUR 21000
Description: 137705-39-6

Glycitein

540183 10.0mg
EUR 190

Glycitein, >99%

BC035-005 5mg
EUR 278.4

Glycitein, >99%

BC035-010 10mg
EUR 375.6

Glycitein, >99%

BC035-025 25mg
EUR 489.6

Glycitein

HY-N0016 10mg
EUR 357.6

Glycitein

GL7698-10 10
EUR 152.2

Glycitein

GL7698-25 25
EUR 248.6

Glycitein

G635400 10mg
EUR 58
Description: 40957-83-3

Glycitein

N1785-20 20 mg
EUR 160
Description: Flavonoid isoflavone

Glycitein

T6S0325-10mg 10mg Ask for price
Description: Glycitein

Glycitein

T6S0325-1g 1g Ask for price
Description: Glycitein

Glycitein

T6S0325-1mg 1mg Ask for price
Description: Glycitein

Glycitein

T6S0325-50mg 50mg Ask for price
Description: Glycitein

Glycitein

T6S0325-5mg 5mg Ask for price
Description: Glycitein

Glycitein

TB0372-0020 20mg
EUR 248.4

Glycitein-7-O-methyl Ether

G214700 1g
EUR 1200
Description: 75199-40-5

6''-O-xylosyl-glycitin

TBW00285 5mg
EUR 1040.4

6''-O-xylosyl-glycitin

TN3194-10mg 10mg Ask for price
Description: 6''-O-xylosyl-glycitin

6''-O-xylosyl-glycitin

TN3194-1g 1g Ask for price
Description: 6''-O-xylosyl-glycitin

6''-O-xylosyl-glycitin

TN3194-1mg 1mg Ask for price
Description: 6''-O-xylosyl-glycitin

6''-O-xylosyl-glycitin

TN3194-50mg 50mg Ask for price
Description: 6''-O-xylosyl-glycitin

6''-O-xylosyl-glycitin

TN3194-5mg 5mg Ask for price
Description: 6''-O-xylosyl-glycitin

Human Glycine(Glycine)ELISA Kit

YLA3881HU-48T 48T Ask for price

Human Glycine(Glycine)ELISA Kit

YLA3881HU-96T 96T Ask for price

Glycine

abx082341-500g 500 g
EUR 243.6

Glycine

abx082391-500g 500 g
EUR 226.8

Glycine

20-abx082501
  • Ask for price
  • Ask for price
  • Ask for price
  • 1 kg
  • 500 g
  • 5 kg

Glycine

09591-55 500G
EUR 45.5

Glycine

17109-22 25G
EUR 8.75

Glycine

17109-35 500G
EUR 17.43

Glycine

17109-64 10KG
EUR 127.4

Glycine

17128-14 100G
EUR 19.6

Glycine

17141-24 100G
EUR 14

Glycine

17141-95 500G
EUR 30.8

Glycine

18-107 250g/Unit
EUR 32.97
Description: Molecular/Proteomic Grade

Glycine

18-108 500g/Unit
EUR 59.88
Description: Molecular/Proteomic Grade

Glycine

18-109 1000g/Unit
EUR 103.17
Description: Molecular/Proteomic Grade

Glycine

40700044-1 500 g
EUR 37.33

Glycine

40700044-2 1 kg
EUR 60.54

Glycine

40700044-3 2 kg
EUR 102.65

Glycine

40700044-4 5 kg
EUR 224.21

Glycine

20-abx184699
  • Ask for price
  • Ask for price
  • 100 g
  • 500 g

Glycine

A2715-1KG 1KG
EUR 46.2
Description: Biotechnology

Glycine

A2715-500G 500G
EUR 26.4
Description: Biotechnology

Glycine

A2715-5KG 5KG
EUR 193.6
Description: Biotechnology

Glycine

HY-Y0966 1g
EUR 142.8

Glycine

GM2385-1 1
EUR 33.9

Glycine

GM2385-100 100
EUR 10.3

Glycine

GM2385-100G 100 g
EUR 44.4

Glycine

GM2385-1KG 1 kg
EUR 60

Glycine

GM2385-250 250
EUR 12.3

Glycine

GM2385-250G 250 g
EUR 46.8

Glycine

GM2385-5 5
EUR 119.1

Glycine

GM2385-500 500
EUR 19.4

Glycine

GM2385-500G 500 g
EUR 51.6

Glycine

GM2385-5KG 5 kg
EUR 112.8

Glycine

G03560 100G
EUR 102.1

Glycine, 99%

G0610-100 1Kg
EUR 160.8

Glycine, 99%

G0610-500 5kg
EUR 361.2

Glycine

G615990 10g
EUR 64
Description: 56-40-6

Glycine

GB0235 500g
EUR 82.97

Glycine

PCT0310-500G 1 unit
EUR 14.98
Description: Glycine

Glycine

PCT0310-5KG 1 unit
EUR 123.27
Description: Glycine

Glycine

MB013-100G 1 unit
EUR 6.93
Description: Glycine

Glycine

MB013-1KG 1 unit
EUR 25.21
Description: Glycine

Glycine

MB013-500G 1 unit
EUR 14.06
Description: Glycine

Glycine

MB013-5KG 1 unit
EUR 81.98
Description: Glycine

glycine

T2O2728-10mg 10mg Ask for price
Description: glycine

glycine

T2O2728-1g 1g Ask for price
Description: glycine

glycine

T2O2728-1mg 1mg Ask for price
Description: glycine

glycine

T2O2728-50mg 50mg Ask for price
Description: glycine

glycine

T2O2728-5mg 5mg Ask for price
Description: glycine

(S)-Glycidol

20-abx181471
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 g
  • 25 g
  • 5 g

Glycine (BSA)

20-abx165740
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Glycine (OVA)

20-abx165741
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Glycine [BSA]

DAG3313 250ug
EUR 858

GLYCINE 2.5KG

IB70194 -
EUR 118.24

GLYCINE 5KG

IB70195 -
EUR 219.46

Glycidol 95%

G03450 25ML
EUR 196.03

(S)-(-)-Glycidol

G615690 1g
EUR 58

(R)-(+)-Glycidol

G615695 10g
EUR 158
Description: 57044-25-4

Glycidol

G615700 1g
EUR 80
Description: 556-52-5

Glycidol (~90%)

G615703 10g
EUR 98
Description: 556-52-5

Glycine, 1kg

PR0608-1kg each Ask for price

Glycinol

TN6568-10mg 10mg Ask for price
Description: Glycinol

Glycinol

TN6568-1g 1g Ask for price
Description: Glycinol

Glycinol

TN6568-1mg 1mg Ask for price
Description: Glycinol

Glycinol

TN6568-50mg 50mg Ask for price
Description: Glycinol

Glycinol

TN6568-5mg 5mg Ask for price
Description: Glycinol

IOX2(Glycine)

A4189-10 10 mg
EUR 72
Description: HIF-1α prolyl hydroxylase-2 (PHD2) inhibitor

IOX2(Glycine)

A4189-5.1 10 mM (in 1mL DMSO)
EUR 68
Description: HIF-1α prolyl hydroxylase-2 (PHD2) inhibitor

IOX2(Glycine)

A4189-50 50 mg
EUR 280
Description: HIF-1α prolyl hydroxylase-2 (PHD2) inhibitor

IOX2(Glycine)

A4189-S Evaluation Sample
EUR 22
Description: HIF-1α prolyl hydroxylase-2 (PHD2) inhibitor

Glycine-d2

G615991 1g
EUR 150
Description: 4896-75-7

Glycine-d5

G615992 100mg
EUR 532
Description: 4896-77-9

Glycine-​1-​13C-​15N

G615999 500mg
EUR 1200
Description: 112898-03-0

Glycine-N,N,O-d3

G616006 10mg
EUR 64
Description: 4896-76-8

Glycidol - 1ML

S-2087 1ML
EUR 178.2

Glycine (Gly) CLIA Kit

20-abx490614
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Glycine-HCI, 1X

18-159 500ml/Unit
EUR 60.27
Description: pH 3.0

10X TRIS GLYCINE

IB01160 SDS BUFFER 1L
EUR 60.92
Description: (REF)

Glycidol-d5

G615702 100mg
EUR 133
Description: 1246819-20-4

Glycine-15N

G615989 50mg
EUR 111

Glycine-13C

G615994 10mg
EUR 287
Description: 20220-62-6

Glycine-15N,d2

G615996 100mg
EUR 224

250G Glycine - 250G

NAT1046 250G
EUR 59.4

Glycine, Hi-AR™/ACS

GRM199-100G 1 unit
EUR 6.93
Description: Glycine, Hi-AR™/ACS

Glycine, Hi-AR™/ACS

GRM199-250G 1 unit
EUR 10.08
Description: Glycine, Hi-AR™/ACS

Glycine, Hi-AR™/ACS

GRM199-500G 1 unit
EUR 12.79
Description: Glycine, Hi-AR™/ACS

Glycine, Hi-AR™/ACS

GRM199-5KG 1 unit
EUR 156.9
Description: Glycine, Hi-AR™/ACS

Glycine (Gly) ELISA Kit

20-abx258882
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Glycine (Gly) ELISA Kit

EKU10876-48T 48T
EUR 690.97

Glycine (Gly) ELISA Kit

EKU10876-5x96T 5x96T
EUR 4688.73

Glycine (Gly) ELISA Kit

EKU10876-96T 96T
EUR 987.1

Glycine (Gly) ELISA Kit

EKN51987-48T 48T
EUR 429.73

Glycine (Gly) ELISA Kit

EKN51987-5x96T 5x96T
EUR 2916.03

Glycine (Gly) ELISA Kit

EKN51987-96T 96T
EUR 613.9

Gly(Glycine) ELISA Kit

ELK8276-48T 48T Ask for price
Description: This assay employs the competitive inhibition enzyme immunoassay technique. The microtiter plate provided in this kit has been pre-coated with Gly protein. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Gly. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Gly in the samples is then determined by comparing the OD of the samples to the standard curve.

Gly(Glycine) ELISA Kit

ELK8276-96T 96T Ask for price
Description: This assay employs the competitive inhibition enzyme immunoassay technique. The microtiter plate provided in this kit has been pre-coated with Gly protein. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Gly. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Gly in the samples is then determined by comparing the OD of the samples to the standard curve.

Glycidamide

540182 100.0mg
EUR 450

Glycine Buffer 5X, pH 3.0

22050015-1 100 mL
EUR 31.43

Glycine Buffer 5X, pH 3.0

22050015-2 500 mL
EUR 85.98

Glycine Buffer 1M, pH 9.0

40121188-2 500 mL
EUR 46.67

Glycine Buffer 1M, pH 9.0

40121188-3 250 mL
EUR 37.33

Cobalt glycine

C23550 5G
EUR 106.45

Glycine, EP, USP grade

GM2320-1 1
EUR 45.2

Glycine, EP, USP grade

GM2320-100 100
EUR 11.8

Glycine, EP, USP grade

GM2320-100G 100 g
EUR 48

Glycine, EP, USP grade

GM2320-1KG 1 kg
EUR 74.4

Glycine, EP, USP grade

GM2320-250 250
EUR 16.4

Glycine, EP, USP grade

GM2320-250G 250 g
EUR 54

Glycine, EP, USP grade

GM2320-5 5
EUR 158.8

Glycine, EP, USP grade

GM2320-500 500
EUR 25.5

Glycine, EP, USP grade

GM2320-500G 500 g
EUR 60

Glycine, EP, USP grade

GM2320-5KG 5 kg
EUR 170.4

Glycine-1-13C

G201152 100mg
EUR 63
Description: 20110-59-2

Glycidamide

G615250 100mg
EUR 196
Description: 5694-00-8

Glycine-13C2

G615998 100mg
EUR 142
Description: 67836-01-5

Glycine Assay Kit

MET-5070 100 assays
EUR 390

Zinc Glycinate

Z439670 1g
EUR 87

Glycidamide

T31954-10mg 10mg Ask for price
Description: Glycidamide